少即是多：脓毒症休克中的儿茶酚胺节约策略 - Suppr | 超能文献

相似文献

1

Less is more: catecholamine-sparing strategies in septic shock.少即是多：脓毒症休克中的儿茶酚胺节约策略

Intensive Care Med. 2019 Dec;45(12):1810-1812. doi: 10.1007/s00134-019-05770-3. Epub 2019 Sep 13.

2

Vasopressor dosing in septic shock.感染性休克中的血管活性药物剂量

Crit Care Med. 2013 Dec;41(12):e483-4. doi: 10.1097/CCM.0b013e3182916fe7.

3

Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.外源性精氨酸加压素在儿茶酚胺难治性感染性休克治疗中的作用

Crit Care Nurse. 2006 Dec;26(6):17-23.

4

The authors reply.作者回复。

Crit Care Med. 2013 Dec;41(12):e484. doi: 10.1097/CCM.0000000000000015.

5

Dear vasopressin, where is your place in septic shock?亲爱的血管加压素，你在感染性休克中扮演着怎样的角色？

Crit Care. 2005 Apr;9(2):134-5. doi: 10.1186/cc2996. Epub 2004 Nov 15.

6

Multimodal strategy to counteract vasodilation in septic shock.多模态策略对抗脓毒性休克中的血管扩张。

Anaesth Crit Care Pain Med. 2023 Jun;42(3):101193. doi: 10.1016/j.accpm.2023.101193. Epub 2023 Jan 5.

7

The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.血管加压素对儿茶酚胺抵抗性脓毒症和心脏术后休克患者全身血流动力学的影响：一项回顾性分析

Anesth Analg. 2001 Jul;93(1):7-13. doi: 10.1097/00000539-200107000-00003.

8

[Vasopressin in distributive shock : Brief summary of the guidelines of the Canadian Critical Care Society published in December 2019].[血管加压素在分布性休克中的应用：2019年12月发表的加拿大重症医学会指南简要概述]

Anaesthesist. 2020 Mar;69(3):159-161. doi: 10.1007/s00101-020-00742-5.

9

New evidence for old therapies in catecholamine-dependent septic shock.儿茶酚胺依赖性感染性休克中旧疗法的新证据

Intensive Care Med. 2001 Apr;27(4):787-90. doi: 10.1007/s001340100866.

10

Broad spectrum vasopressors: a new approach to the initial management of septic shock?广谱血管加压素类药物：脓毒性休克初始治疗的新方法？

Crit Care. 2019 Apr 16;23(1):124. doi: 10.1186/s13054-019-2420-y.

引用本文的文献

1

Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents.心脏之外：探索血管活性药物非心血管效应的综述

Front Pharmacol. 2025 Jul 10;16:1533437. doi: 10.3389/fphar.2025.1533437. eCollection 2025.

2

Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.早期辅助亚甲蓝治疗感染性休克患者的随机对照试验。

Crit Care. 2023 Mar 13;27(1):110. doi: 10.1186/s13054-023-04397-7.

3

Timing of vasoactive agents and corticosteroid initiation in septic shock.感染性休克中血管活性药物和皮质类固醇起始使用的时机。

本文引用的文献

1

Blood Purification and Mortality in Sepsis and Septic Shock: A Systematic Review and Meta-analysis of Randomized Trials.血液净化治疗脓毒症和感染性休克患者的死亡率：一项随机试验的系统评价和荟萃分析。

Anesthesiology. 2019 Sep;131(3):580-593. doi: 10.1097/ALN.0000000000002820.

2

Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.脓毒性休克复苏中早期使用去甲肾上腺素（CENSER）：一项随机试验。

Am J Respir Crit Care Med. 2019 May 1;199(9):1097-1105. doi: 10.1164/rccm.201806-1034OC.

3

Adjunctive Corticosteroid Treatment in Septic Shock.